6 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
acute coronary syndrome ... patients (ACS) has ... Switching Between Intravenous ... to Prasugrel, Clopidogrel ... ticagrelor #prasugrel #pharmacology
Intravenous Lipid Emulsion (ILE) Therapy

ILE is a treatment for severe toxicity from local anesthetics. In addition,
Intravenous Lipid ... In addition, it has ... Kat_Watson #Intravenous ... Therapy #Toxicology #Management ... #Pharmacology #
Hepatorenal Syndrome Treatment
Volume expansion: 
 • Albumin (typical dose = 1g/kg on day 1 +/- day
Hepatorenal Syndrome ... terlipressin (intravenous ... #Hepatorenal #Syndrome ... #Treatment #management ... #HRS #nephrology
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
of Hepatorenal Syndrome ... (HRS) Midodrine ... amzn.to/34t5DgJ #HRS ... #Nephrology #Management ... #Pharmacology #
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Propofol infusion syndrome ... x > 6 hrs) can ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
Methotrexate Toxicology 

Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
Toxicology Intravenous ... for determining intravenous ... the following has ... Toxicology #Toxicity #Management ... #Pharmacology